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Abstract  
Background: Pain from advanced cancer remains prevalent, severe and often under-treated.  
Aim: Conduct a discrete choice experiment (DCE) with patients to understand their preferences for 
pain management services and inform service development.   
Design: Focus groups were used to develop the DCE attributes and levels. The attributes were: 
waiting time, type of healthcare professional, out-of-pocket costs, side-effect control, quality of 
communication, quality of information, and pain control. Patients completed the DCE along with 
clinical and health-related quality of life (HRQoL) questions. Conditional and mixed logit models were 
used to analyse the data.  
Results: Patients with cancer pain (n=221) and within palliative care services completed the survey 
(45% female; mean age=64.6, range 21-92). The most important aspects of pain management were: 
good pain control, zero out-of-pocket costs and good side-effect control. Poor or moderate pain 
control and £30 costs drew the highest negative preferences. Respondents preferred control of side 
effects and provision of better information and communication, over access to certain health care 
professionals. Those with lower HRQoL were less willing to wait for treatment and willing to incur 
higher costs. The presence of a carer influenced preferences. 
Conclusions: Outcomes attributes were more important than process attributes but the latter were 
still valued. Thus, supporting self-management, for example by providing better information on pain 
may be a worthwhile endeavour. However service provision may need to account for individual 
characteristics given heterogeneity in preferences.  
 
Key findings and implications 
x Patients value control of side effects and provision of better information, areas of care that 
are often poorly addressed.  
x High out-of-pocket costs and long waits may deter treatment seeking at the end of life.  
x Patients with poorer health-related QoL and those without family carers have different 
service preferences and these should be accounted for in service provision.  
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1. Introduction 
Severe pain is experienced by over 50% of cancer patients in the last three months of life with only 
8% reporting improvements in pain levels after receiving care.[1] Despite the efficacy of the WHO 
analgesic ladder approach to interventions, a European survey of 5,000 cancer patients found that 
72% still experienced pain, 90% of which was of moderate-to-severe intensity.[1] Elsewhere, a US 
study found that 33% of cancer patients experiencing pain were receiving inadequate analgesic 
prescriptions.[2] Evidently, cancer pain is not being managed optimally [3], compromising the quality 
of life of patients [4, 5] and leading to greater healthcare costs, for example through increases in 
emergency admissions.[6] 
Most patients with advanced cancer prefer to be cared for at home and to die at home.[7] Current 
NHS policy in England advocates a multidisciplinary approach to management of patients with 
advanced disease that prioritises pain and symptom management.[8] However, one UK regional 
study showed that poor pain control is the most frequent reason that cancer patients at home 
request urgent medical help.[9] This suggests that current service provision is not adequate and that 
improved support for community based self-management of cancer pain is needed. Improving the 
Management of Pain from Advanced Cancer in the Community (IMPACCT) is a UK research 
programme aimed at facilitating this.[10]  
Eliciting patient preferences is important in clinical service design.[11, 12] Stated preference survey 
techniques such as discrete choice experiments (DCE) and best-worst scaling (BWS) surveys are 
increasingly being used to understand what is important to patients, particularly those with 
cancer.[13, 14] Preference elicitation techniques are important in economics because they force 
respondents to weigh-up the costs and benefits of possible alternatives and to make choices and 
trade-offs. In doing so, a closer ĂƉƉƌŽǆŝŵĂƚŝŽŶŽĨŚŽǁŵƵĐŚ ‘ǀĂůƵĞ ?respondents really place on the 
options and their attributes is gained compared to simply asking them what their preferences 
are.[15] 
Several studies have established preferences for cancer treatments (e.g.[16]), pain care services [17] 
and to determine the trade-offs between pain control and side effects.[18, 19] However, only one 
(US-based) study has been conducted solely with cancer patients to understand their preferences for 
pain management.[20] This study found that the most important aspect of analgesic treatment for 
ƉĂƚŝĞŶƚƐ ǁĂƐ  ‘percĞŶƚ ƉĂŝŶ ƌĞůŝĞĨ ǁŝƚŚ ĂŶĂůŐĞƐŝĐƐ ? ?[20] The findings have limited value for service 
planning as the study did not go beyond opioid treatments to consider preferences for wider aspects 
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of pain management which are more related to the process of care such as information, waiting 
times and the type of healthcare professional providing care. 
The aim of this research was to address this knowledge gap by conducting a preference survey 
exclusively with cancer patients experiencing pain in England. The survey sought to establish which 
aspects of pain management are most important to patients and their willingness to trade off 
between these in order to inform future service development policies.  
 
2. Methods  
Design: We conducted a discrete choice experiment (DCE) survey where respondents were 
presented with two unlabelled descriptions of hypothetical pain management services. The 
ĚĞƐĐƌŝƉƚŝŽŶƐ ĐŽŶǀĞǇ ĚŝĨĨĞƌĞŶƚ ƐĞƌǀŝĐĞ  ‘ĂƚƚƌŝďƵƚĞƐ ?  ?Ğ ?Ő ?  ‘ĐŽŶƚĂĐƚ ǁŝƚŚ 'W ? ? ĂŶĚ  ‘ůĞǀĞůƐ ?  ?Ğ ?Ő ?  ‘tĞĞŬůǇ
ƉŚŽŶĞĐĂůů ?ǀƐ ? ‘DŽŶƚŚůǇǀŝƐŝƚ ? ?ǁŝƚŚŝŶĞĂĐŚĂƚƚƌŝďƵƚĞ ?[14] Respondents are asked to consider the pain 
management service descriptions and choose which they would prefer to receive. In making their 
choices, respondents are assumed to estimate which would yield the overall greatest utility (or 
ǀĂůƵĞ ?ĨŽƌƚŚĞŵ ?ZĞƐƉŽŶĚĞŶƚƐĐŽŵƉůĞƚĞƐĞǀĞƌĂůŽĨƚŚĞƐĞ ‘ĐŚŽŝĐĞƚĂƐŬƐ ?ŝŶƚŚĞsurvey where some or 
Ăůů ŽĨ ƚŚĞ ůĞǀĞůƐ ŽĨ ŽƉƚŝŽŶƐ ĂƌĞ ĂůƚĞƌĞĚ ? Ǉ ŽďƐĞƌǀŝŶŐ ƉĂƌƚŝĐŝƉĂŶƚƐ ? ƌĞƐƉŽŶƐĞƐ ƚŽ ĐŚĂŶŐĞƐ ŝŶ ƚŚĞ
options, it is possible to quantify the relative strength of preference for the different attributes and 
levels presented and willingness to trade-off between them.  
Attribute development: We followed guidance for the DCE design and development by incorporating 
qualitative research.[21, 22] We generated the content of the DCE survey through a literature review 
and focus group (n=2) work with patients (n=10; 40% male, median age=70; age range =48-86) with 
pain from advanced cancer who attended one of two hospices in Leeds. A topic guide (included in 
supplementary material) was developed following a scoping review and discussion with clinicians 
and used to facilitate the focus groups. Patients were asked to talk about their cancer pain, how well 
it was controlled, important aspects of pain management, the care they received and any service 
improvements they would like to see. Focus groups were audio recorded, transcribed verbatim and 
analysed by two researchers using thematic analysis following the recommendations set by Braun 
and Clarke aiming to identify key themes.[23] The transcripts were managed in NVivo (©QSR 
International, 2012). Key themes identified by the qualitative analysis of the focus groups included 
the supply of pain medications, the role of day centres/hospices, access to medications and 
education on morphine use (see supplementary material for full results summary). A long list of 16 
attributes (supplementary Table A) was arrived at via consensus meetings between researchers, 
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clinicians and nurses after discussion of the focus group results. A ranking exercise was conducted 
with a group of healthcare professionals (N=24) to reduce the list to a practicable number and to 
suggest attribute levels. A meeting was held with the healthcare professionals and they were 
presented with, and allowed to discuss, the draft attributes. They were then asked individually to 
rank order the eight attributes they felt were most important to patients. The ranking scores, focus 
group material and additional clinical expertise were used to refine the attributes including the 
collapsing and removal of some. The levels for out-of-pocket costs were informed by a previous 
feasibility survey covering healthcare resource use and patient costs completed in this patient group 
and part of the same research programme.  Of the final seven attributes, four were comprised of 
three levels and three were comprised of two levels. The language of the final attributes and levels 
(shown in Table 1) were tested with patients prior to the main survey. 
DCE survey: Ngene software (version 1.1.1 ©ChoiceMetrics Pty Ltd, Sydney, Australia) was used to 
create an efficient design of the DCE survey by maximizing D-efficiency. The design resulted in 36 
binary choice sets that were divided into 6 blocks of 6 choice sets each. Each of the choice sets had 
all of the attributes present and all of the levels were represented but in different combinations 
across the 6 sets. Priors were not included in the design and, since there was no strong expectation 
of heterogeneity, interactions were also omitted. Each respondent was randomly allocated one 
block consisting of six choice tasks. In addition to the choice tasks, respondents completed socio-
demographic questions, cancer and pain-related questions and the EQ-5D questionnaire.[24] 
Sampling: Community-based patients with pain from advanced cancer who were aged 18 and over 
were eligible for the study. Advanced cancer was defined as metastatic cancer or that receiving 
palliative therapy. Patients with pain were defined as those receiving analgesic treatment for cancer 
symptom-related or therapy-related pain. Patients had to be able to complete the questionnaires 
and provide informed consent to participate. Patients completed the DCE in a pen and paper format 
with the research nurse present to help provide clarification if necessary. Thirteen palliative care 
services across England recruited patients to the study. Pre-specifying the required sample size for a 
DCE is complex, relying as it does on a priori knowledge of the parameters to be estimated in the 
models.[21] However, based on previous experience, we were confident that a sample of n=200 
(assuming 7 attributes each with d3 levels and 6 choice task completions by each respondent) would 
provide sufficient data to estimate robust models. Ethical approval was granted by NRES Committee 
South East Coast - Brighton and Sussex (Reference: 13/LO/0662). 
Analysis: The data was analysed using conditional and mixed logit models. The size and direction of 
the coefficient indicated the importance of that level in determining the choice of the individual and 
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can be considered to represent preference weights.[14] The model coefficients were used to provide 
marginal rates of substitution between different pain management attributes, denoting 
ƌĞƐƉŽŶĚĞŶƚƐ ?ǁŝůůŝŶŐŶĞƐƐƚŽ  ‘ƚƌĂĚĞ-ŽĨĨ ? ?dŽĨĂĐŝůŝƚĂƚĞƚŚŝƐ ?ƚŚĞ ůĞǀĞůƐŽĨƚǁŽĂƚƚƌŝďƵƚĞƐ  ?ŽƵƚ-of-pocket 
costs and waiting time) were entered into the model as continuous variables. The central value of 
the range was taken as the value for waiting time. dŚĞ  ‘ŽƵƚ-of-ƉŽĐŬĞƚĐŽƐƚƐ ?ĂƚƚƌŝďƵƚĞǁĂƐƵƐĞĚĂƐ
the subjective valuation mechanism; however, we acknowledge the values produced may not reflect 
willingness to pay for services. All other explanatory variables were treated as categorical and 
dummy coded in the analysis. Interactions were tested between attribute levels and sub-groups to 
test for heterogeneity of preferences. Sub-groups tested were: age group (above/below median of 
66 years); gender; whether patients had an informal carer (defined as completion of a carer 
questionnaire) or not; cancer duration groups (above/below median of 1.5 years); pain severity 
groups (mild vs. moderate/severe); pain relief groups (<70% vs. A? ? ?A? ? ?EQ-5D groups (above/below 
median of 0.52); and healthcare cost groups (above/ below median monthly cost of £430). We also 
ran a model using effects coding [25] for categorical variables; as this provides a coefficient for all 
levels we can illustrate the preference change with each level. The mixed logit model informed on 
the level of unobserved heterogeneity in the preferences; we assumed this was present in all 
parameters and tested this by allowing all to be random in the analysis. Relative model quality was 
judged using Akaike and Bayesian Information Criterion values (AIC and BIC). All analyses were 
conducted in STATA (©StataCorp, Texas, USA).  
3. Results 
3.1. Patient sample: Two hundred and forty-eight patients were recruited and completed the 
survey. There were some missing data with 27 (10.9%)  completing the resource use and quality of 
life sections of the survey but not attempting the DCE section. There was    3% missing or spoilt 
responses from those who did complete the DCE section. Pearson Chi2 tests indicated that non-
completion of the DCE was not related to gender or pain severity but there was a trend that those in 
the older age group (over 66 years) were less likely to complete the survey (p=0.032). Those whose 
highest level of education was secondary school also appeared more likely to not complete the DCE 
than those who received a college or university education (p=0.002). The sample characteristics are 
included in Table 2. Almost all participants were white Caucasian but there was a good distribution 
across pain severity and EQ-5D scores. See supplementary material for block completion samples. 
3.2. DCE analysis: Results of the conditional logit model and mixed logit model are included in Table 
3. Conditional Logit: Squared terms for the waiting time and cost attributes were not significant and 
excluded from the final model. The model and coefficients were significant with all the estimated 
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preference coefficients being negative. Thus, less desirable levels were associated with reduced 
utility which indicated that the survey had theoretical validity. The ordering of the level coefficients 
for the pain control attribute was also as anticipated: moderate pain control was worse than good 
control, and poor pain control was worse still. Limited non-satiation tests were possible due to the 
survey design but indicated that only 2.7% of people provided an irrational response (in 36 choices). 
Preference weights for the levels with effects coding are shown in Figure 1. The greatest preference 
was for good pain control with lower levels of positive preferences for immediate service (0 waiting 
time), seeing a specialist pain doctor, incurring no out-of-pocket costs, having good side-effect 
control and good communication and information. By some margin the level leading to the greatest 
utility decrement was poor pain control, followed by an out-of-pocket expense of £30 and then 
moderate pain control. We conducted an exploration of dominance in responses and did find 
evidence for this. For example, 33.5% of respondents always chose the option where pain control 
was better, compared to 4% always choosing an option based on waiting time.  
A number of the interactions between attribute level and respondent characteristic were significant 
(see supplementary Table B). Males were more averse to poor side-effect control than females 
(p=0.042). Those with lower EQ-5D scores were less willing to accept poorly controlled side-effects 
(p=0.026), less willing to wait for treatment (p=0.002) and willing to incur higher out-of-pocket costs 
(p=0.021) in receiving pain management. Those who had cancer for longer were more averse to 
severe pain (p=0.036), perhaps reflecting real experiences of sub-optimal management. There also 
appeared to be some heterogeneity according to the level of support an individual had as those who 
had a carer were more likely to accept pain management by a GP (p=0.017) and willing to incur 
higher out-of-ƉŽĐŬĞƚĐŽƐƚƐ ?ƉA? ? ? ? ? ? ?ƚŚĂŶƚŚŽƐĞǁŚŽĚŝĚŶ ?ƚŚĂǀe a carer. Interactions with pain level 
(mild vs. moderate or severe) were largely insignificant although, counter-intuitively, those who had 
mild pain were more averse to waiting for treatment.  A finding more in line with expectations was 
that those with poor pain relief (<70%) were less willing to wait for treatment. 
Mixed Logit: The mixed logit model appeared to improve fit statistics however preference weights 
were very similar to those for the conditional logit model (Table 3). Notable differences were an 
increased disutility associated with specialist pain nurse care, poor side-effect control and poor 
information in the mixed logit model. This model also had the effect of decreasing the disutility 
associated with moderate pain control and increasing it slightly for poor pain control. The results 
indicated that there may be significant heterogeneity in four parameters: waiting time, out-of-
pocket costs, communication and good pain control. Although on average patients preferred lower 
wait times, lower cost, good communication and good pain control the results suggest there may 
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have been some heterogeneity present. From the magnitudes of the mean estimates and the 
corresponding standard deviations, z scores (standard normal distribution) were calculated and 
indicate that 8% preferred longer waiting times, 14% preferred higher costs, 8% preferred poor 
communication and 3% did not prefer good pain control.   
We calculated willingness to wait and pay based on mixed logit models by keeping the cost or wait 
time as fixed (and all others random). Table 4 includes the trade-offs in the form of willingness to 
wait and pay for the different pain management attributes based on the mixed logit results. On 
average, patients valued a reduction of one day in waiting time as equivalent to £7.72. This may also 
be interpreted as meaning that patients were willing to incur costs of £7.72 to avoid waiting a day 
for treatment. Similarly, patients valued seeing a specialist pain doctor rather than a GP as 
equivalent to £23.80 and good side-effect control, good information and communication (vs. poor) 
were valued between £27 and £35. Avoiding poor pain control was highly valued at around £83 per 
month. When the trade-off was between the waiting time and the rest of the treatment aspects, 
patients would be willing to wait 3.26 days longer to see a specialist pain Dr rather than a GP and 
approximately an additional 3.5-4-5 days to achieve good side-effect control and to receive good 
information and communication. Willingness to wait for good pain control (vs. poor) was much 
higher, an average of just over 11 days.  
4. Discussion  
We found that the most important aspects of pain management were: good pain control, incurring 
zero out-of-pocket costs and good control of side-effects. Poor and moderate pain control and £30 
out-of-pocket costs drew the highest negative preference weights. There was little evidence that 
patients were willing to trade pain outcomes for aspects of process, (or health for process utility) as 
the pain attribute was much more important than the others presented. However, the other 
outcome attribute (control of side-effects) was much less powerful and good side-effect control 
yielded preference weights similar to receiving good information about pain management and 
seeing a specialist pain doctor. Previous studies have suggested the negative impact of analgesic 
side-effects was significant and that patients would often trade-off pain control against the side-
effects of pain medications. For example, Chancellor et al [18] found pain impact was second in 
importance to nausea side-effects in their DCE and Gregororian et al [19] found that both chronic 
and acute pain patients rated avoiding vomiting as more important than pain relief; nausea was 
almost as important. These findings are echoed elsewhere although Meghani and colleagues found it 
was the type of side-effects (with nausea and vomiting being the worst) that was more important 
than their severity.[20] 
10 
 
In general, patients preferred to be seen by a healthcare professional other than a GP; this may be a 
real preference reflecting experiences but may have been influenced by the level descriptors of 
 ‘ƐƉĞĐŝĂůŝƐƚ ? pain doctor or nurse for the other two attribute levels. The preference weights suggest 
that, while respondents preferred immediate treatment with zero out-of-pocket costs, they were 
willing to wait a few days for treatment and incur some costs (£10). Respondents were willing to 
incur costs ranging £23.80 to £34.42 to reduce waiting time by 4 days, receive good information and 
communication (vs. poor) and to see a specialist pain doctor (rather than a GP). However, they were 
willing to incur costs over £83 to receive good pain control. For the superior attribute levels, patients 
were willing to wait around 4 days but would wait over 11 days for good pain control (vs. poor).  
A number of the interaction effects were significant suggesting pain management preferences 
depend on patient characteristics and circumstances, especially ƉĂƚŝĞŶƚƐ ? level of health-related 
quality of life (HRQoL) and whether they have an informal carer or not. Several of these effects 
appear to provide evidence of the internal validity of the DCE. For example, those with lower HRQoL 
were less willing to wait for treatment and willing to incur higher out-of-pocket costs. The mixed 
logit results also indicate significant heterogeneity in preferences for several of the service aspects. 
For a small minority, there was a suggestion of counter-intuitive preferences (e.g. prefer longer wait 
times for treatment); this may be due to a lack of participant understanding or engagement or be an 
artefact of the survey design. 
Strengths and limitations  
This is the most in-depth study to date employing stated preference techniques to elicit the 
preference of cancer patients in palliative care for pain management. The use of DCE methodology 
ĞŶĂďůĞĚ ƚŚĞĐĂƉƚƵƌĞŽĨ  ‘ƉƌŽĐĞƐƐ ?ƵƚŝůŝƚǇ ? ƚŚĞǀĂůƵĞƉůĂĐĞĚŽŶƐĞƌǀŝĐĞƐĂŶĚ ŝŶƚĞƌǀĞŶƚŝŽŶƐ ƚŚĂƚ ŝƐŶŽƚ
readily measurable by the standard quality-adjusted life year (QALY) approach.[26, 27] For example, 
feeling confident about how much morphine to take may have little value in the QALY framework  
but here was shown to be important to patients in terms of the value placed on good information. 
While overwhelmingly patients preferred positive pain outcomes, it was clear that people also 
valued process aspects of service including good information and communication.  
While the design of the survey was based on patient input, the sample size for the qualitative aspect 
of the study was probably below the optimal. In addition, we relied in part on healthcare 
professionals to inform attribute selection and this may have led to a different DCE design than had 
we relied solely on patients. However, the substantial breadth and depth of experience of the 
healthcare professionals brought was valuable and the survey was checked with patients prior to 
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being finalised. As the survey sample were almost all white Caucasian and since those who 
completed the survey had higher levels of education than ƚŚŽƐĞǁŚŽĚŝĚŶ ?ƚ ?ƚŚĞŐĞŶĞƌĂůŝǌĂďŝůŝƚǇŽĨ
the findings to other groups requires some ĐĂƵƚŝŽŶ ?tĞĚŝĚŶŽƚƚĞƐƚƉĂƚŝĞŶƚ ?ƐƵŶĚĞƌƐƚĂŶĚŝŶŐŽĨƚŚĞ
DCE method although the DCE was carefully explained to individuals. Caution is required in 
ŝŶƚĞƌƉƌĞƚŝŶŐ ƚŚĞ  ‘ǁŝůůŝŶŐŶĞƐƐ ƚŽ ƉĂǇ ? ǀĂůƵĞƐ ĨŽƌ ƚǁŽ ƌĞĂƐŽŶƐ ? ƚŚĞƐĞ ǀĂůƵĞƐ ǁĞƌĞ ďĂƐĞĚ ŽŶa costs 
incurred attribute and they are influenced by the expectations of the respondents. Thus as 
healthcare is free at the point of use in England, these values may not represent the willingness to 
pay should patients be required to pay but, ƌĂƚŚĞƌ ?ǁŚĞƌĞ ŚĞĂůƚŚĐĂƌĞ ŝƐ  ‘ĨƌĞĞ ? ? ƚŚĞǇ ƌĞƉƌĞƐĞŶƚ ƚŚĞ
willingness to incur costs in accessing that care. Thus, the values may not be generalizable to other 
types of healthcare system. However, they still highlight the importance of out-of-pocket costs for 
patients. Finally, as in all stated preference studies, the caveat must be applied that the responses 
may neither accurately reflect true preferences nor reflect well the actual choice behaviour by 
patients in reality.[28] However, in the absence of demand information for new services, it is likely 
that the preferences provided by such surveys can still improve decision making overall. 
Future research could explore the use of stated preference techniques alongside economic 
evaluations to determine the cost-per QALY of each attribute and level and enable the identification 
of services that meet demand but are also cost-effective. This may face several challenges, not least 
the issue of who should value services and interventions, the patient or the general 
population.[29]Additional research is also required to establish the external validity of the survey 
predictions if they are to be the basis for decision making. 
Implications for clinical practice 
Not surprisingly, good pain control was the most important factor in pain management preferences. 
However, patients also valued good information and communication, and  control of side effects. 
Providing information such that the patient has increased confidence in taking analgesics, or 
providing continuity of care, for example, may be relatively low cost routes to improving services. 
GPs were the least preferred healthcare professional; however, the preference for information and 
communication outweighed that for certain healthcare professionals. These findings suggest that 
supporting self-management of cancer pain (for example better information on pain, medicines 
management, dealing with side effects, etc.), would be valued by patients. High out-of-pocket costs 
might deter treatment seeking for patients at the end of life and hence should be minimised where 
possible. The heterogeneity in results also suggests particular attention should be focused on those 
with the lowest HRQoL and for those who do not have an informal carer. These groups of patients 
may feel less supported and had different preferences for care, particularly for more prompt 
12 
 
response by a health care professional. Thus, service development must allow for heterogeneity in 
preferences and be sensitive to personal factors and health status, especially when choices are 
offered. 
5. Conclusions 
The preferences for pain management in advanced cancer were strongest for outcomes but aspects 
of the process of care were also valued. Thus, while pain control should remain the focus, supporting 
self-management, for example by providing better information on pain may be a worthwhile 
endeavour. However service provision may need to account for individual characteristics given 
heterogeneity in preferences. 
Keywords:  discrete choice experiment, cancer pain, patient preferences 
Author contributions: 
David Meads designed the study, analysed the data and wrote the manuscript; John O'Dwyer helped 
design the study, write the protocol, was involved in the generation, testing and refinement of the 
survey and managed data collection; Claire Hulme was involved in the study design and 
interpretation of results; Phani Chintakayala provided guidance on the survey design, analysis and 
interpretation; Karen Vinall-Collier helped with the ethics application, conducted the qualitative 
analysis and helped with site co-ordination; Michael Bennett assisted with the survey design and set-
up, provided clinical input, helped interpret the results and write the paper. 
Ethical approval: All procedures performed in studies involving human participants were in 
accordance with the ethical standards of the institutional and/or national research committee and 
with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. 
Informed consent: Informed consent was obtained from all individual participants included in the 
study. 
13 
 
References 
1. Breivik H, Cherny N, Collett B, De Conno F, Filbet M, Foubert A, et al. Cancer-related pain: a 
pan-European survey of prevalence, treatment, and patient attitudes. Annals of Oncology. 
2009:mdp001. 
2. Fisch MJ, Lee J-W, Weiss M, Wagner LI, Chang VT, Cella D, et al. Prospective, observational 
study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, 
or prostate cancer. Journal of Clinical Oncology. 2012:JCO. 2011.39. 381. 
3. Van den Beuken-van Everdingen M, De Rijke J, Kessels A, Schouten H, Van Kleef M, Patijn J. 
Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Annals of 
oncology. 2007;18(9):1437-49. 
4. Shi Q, Smith TG, Michonski JD, Stein KD, Kaw C, Cleeland CS. Symptom burden in cancer 
survivors 1 year after diagnosis. Cancer. 2011;117(12):2779-90. 
5. Portenoy RK, Lesage P. Management of cancer pain. The lancet. 1999;353(9165):1695-700. 
6. Fortner BV, Okon TA, Portenoy RK. A survey of pain-related hospitalizations, emergency 
department visits, and physician office visits reported by cancer patients with and without history of 
breakthrough pain. The Journal of Pain. 2002;3(1):38-44. 
7. Gomes B, Higginson I, Calanzani N, Cohen J, Deliens L, Daveson B, et al. Preferences for place 
of death if faced with advanced cancer: a population survey in England, Flanders, Germany, Italy, the 
Netherlands, Portugal and Spain. Annals of Oncology. 2012:mdr602. 
8. Department of Health. End of Life Care Strategy: Promoting high quality care for all adults at 
the end of life. July 2008. UK. 
9. Adam R, Wassell P, Murchie P. Why do patients with cancer access out-of-hours primary 
care? A retrospective study. British Journal of General Practice. 2014;64(619):e99-e104. 
10. University of Leeds. 
http://medhealth.leeds.ac.uk/info/655/impacct/907/what_is_the_impacct_programme Last 
accessed 1st April 2015. 
11. Campbell NC, Murray E, Darbyshire J, Emery J, Farmer A, Griffiths F, et al. Designing and 
evaluating complex interventions to improve health care. Bmj. 2007;334(7591):455-9. 
12. Bate P, Robert G. Experience-based design: from redesigning the system around the patient 
to co-designing services with the patient. Quality and Safety in Health Care. 2006;15(5):307-10. 
13. ĚĞĞŬŬĞƌ ?'ƌŽďt ?ZǇĂŶD ?'erard K. Discrete choice experiments in health economics: a 
review of the literature. Health economics. 2012;21(2):145-72. 
14. Clark MD, Determann D, Petrou S, Moro D, de Bekker-Grob EW. Discrete choice experiments 
in health economics: a review of the literature. Pharmacoeconomics. 2014;32(9):883-902. 
14 
 
15. Ryan M, Gerard K, Amaya-Amaya M. Using discrete choice experiments to value health and 
health care: Springer; 2007. 
16. Molassiotis A, Emsley R, Ashcroft D, Caress A, Ellis J, Wagland R, et al. Applying Best W orst 
scaling methodology to establish delivery preferences of a symptom supportive care intervention in 
patients with lung cancer. Lung Cancer. 2012;77(1):199-204. 
17. Mühlbacher AC, Junker U, Juhnke C, Stemmler E, Kohlmann T, Leverkus F, et al. Chronic pain 
ƉĂƚŝĞŶƚƐ ? ƚƌĞĂƚŵĞŶƚ ƉƌĞĨĞƌĞŶĐĞƐ P Ă ĚŝƐĐƌĞƚĞ-choice experiment. The European Journal of Health 
Economics. 2014:1-16. 
18. Chancellor J, Martin M, Liedgens H, Baker MG, Müller-Schwefe GH. Stated preferences of 
physicians and chronic pain sufferers in the use of classic strong opioids. Value in Health. 
2012;15(1):106-17. 
19. Gregorian RS, Gasik A, Kwong WJ, Voeller S, Kavanagh S. Importance of side effects in opioid 
treatment: a trade-off analysis with patients and physicians. The Journal of Pain. 2010;11(11):1095-
108. 
20. Meghani SH, Chittams J, Hanlon AL, Curry J. Measuring preferences for analgesic treatment 
for cancer pain: How do African-Americans and Whites perform on choice-based conjoint (CBC) 
analysis experiments? BMC medical informatics and decision making. 2013;13(1):118. 
21. de Bekker-Grob EW, Donkers B, Jonker MF, Stolk EA. Sample Size Requirements for Discrete-
Choice Experiments in Healthcare: a Practical Guide. Patient. 2015 Oct;8(5):373-84. 
22. ŽĂƐƚ: ?ů ?:ĂŶĂďŝ, ?^ƵƚƚŽŶ: ?,ŽƌƌŽĐŬƐ^ ?sŽƐƉĞƌ: ?^ǁĂŶĐƵƚƚZ ?ĞƚĂl. Using qualitative 
methods for attribute development for discrete choice experiments: issues and recommendations. 
Health economics. 2012;21(6):730-41. 
23. Clarke V, Braun V. Thematic analysis. In Encyclopedia of Critical Psychology (pp. 1947-1952). 
New York: Springer; 2014 
24. Brooks R. EuroQol: the current state of play. Health policy. 1996;37(1):53-72. 
25. Bech M, GǇƌĚ ?,ĂŶƐĞŶ ? ĨĨĞĐƚƐ ĐŽĚŝŶŐ ŝŶ ĚŝƐĐƌĞƚĞ ĐŚŽŝĐĞĞǆƉĞƌŝŵĞŶƚƐ ? ,ĞĂůƚŚ ĞĐŽŶŽŵŝĐƐ ?
2005;14(10):1079-83. 
26. Payne K, McAllister M, Davies LM. Valuing the economic benefits of complex interventions: 
when maximising health is not sufficient. Health economics. 2013;22(3):258-71. 
27. Brennan VK, Dixon S. Incorporating process utility into quality adjusted life years: a 
systematic review of empirical studies. PharmacoEconomics. 2013;31(8):677-91. 
28. Loomis J. What's to know about hypothetical bias in stated preference valuation studies? 
Journal of Economic Surveys. 2011;25(2):363-70. 
15 
 
29. Brazier JE, Dixon S, Ratcliffe J. The role of patient preferences in cost-effectiveness analysis. 
Pharmacoeconomics. 2009;27(9):705-12. 
 
16 
 
Table 1: Final attributes and levels  
Attributes Levels 
Waiting time for reliable medical advice and pain treatment 
No wait 
(Immediate) 
1 to 2 days 3 to 7 days 
The healthcare professional who is responsible for your pain 
management 
Specialist 
Pain Doctor  
Specialist 
Nurse 
Your GP 
Out-of-pocket cost to you per month (e.g. costs such as 
prescriptions, travel, parking & telephone call that you would 
have to pay) 
£0 £10 £30 
Level of control over the side-effects of pain treatments 
Good 
control 
Poor 
control 
  
Level of communication between your GP, pharmacist and you Good Poor   
You are given information which makes you confident about 
taking the right amount of morphine 
Yes No   
Level of pain control during the day and night 
Good 
Control 
Moderate 
Control 
Poor 
Control 
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Table 2: Sample characteristics 
N = 221 Mean (SD) Range 
Gender    
N Female  100 (45.25%) -- 
Age  64.66 (12.27) 21.6-92.2 
Ethnicity   
White 218 (98.64%) -- 
Other  3 (1.36%) -- 
Highest level of education   
University or college or equivalent 63 (28.90%) -- 
Intermediate between secondary level and 
university  
 
51 (23.39%) -- 
Secondary school 102 (46.79%) -- 
Primary school (or less) 2 (0.92%) -- 
Time since diagnosis (years) 3.35 (3.91) 0.4-18 
EQ-5D Utility Index* 0.42 (0.33) -0.43-1 
EQ-5D VAS 55.22 (21.36) 10-100 
Pain severity in last 24 hours (0-10)**   
No or Mild (0-4) 100 (45.66%) -- 
Moderate (5-6) 67 (30.59%) -- 
Severe (7-10) 52 (23.74%) -- 
Pain relief in last 24 hours (0-100%) 64.81 (24.13) 0-100 
How satisfied have you been with the pain management service you received 
over the last month? 
Very satisfied 96 (44.86%) -- 
Quite satisfied 79 (36.92%) -- 
Neither satisfied nor dissatisfied 24 (11.21%) -- 
Quite dissatisfied 9 (4.21%) -- 
Very dissatisfied 6 (2.8%) -- 
*EuroQoL 5 Dimension questionnaire; high scores represent better quality of life 
**Average severity 
 
Table 3: Logit model results  
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Conditional Logit Mixed Logit 
Choice Level E SE E SE 
Waiting time  -0.205** 0.025 -0.255** 0.042 
Professional (Specialist pain Dr vs.)     
Specialist pain nurse -0.566** 0.131 -0.675** 0.232 
GP -0.869** 0.124 -0.812** 0.157 
Cost -0.040** 0.004 -0.034** 0.006 
Side-effect control (Good vs.)     
Poor -1.001** 0.098 -1.118** 0.149 
Communication (Good vs.)     
Poor -0.899** 0.101 -0.890** 0.146 
Information (Good vs.)     
Poor -0.942** 0.103 -1.128** 0.164 
Pain control (Good vs.)     
Moderate -1.154** 0.122 -0.617** 0.206 
Poor -2.683** 0.138 -2.727** 0.297 
Standard Deviation 
 
  
  
Waiting time    0.184** 0.042 
Professional (Specialist pain Dr vs.)      
Specialist pain nurse   0.653 0.232 
GP   0.179 0.157 
Cost   0.031** 0.006 
Side-effect control (Good vs.)      
Poor   0.103 0.149 
Communication (Good vs.)      
Poor   0.644** 0.146 
Information (Good vs.)      
Poor   0.172 0.164 
Pain control (Good vs.)      
Moderate   0.049 0.206 
Poor   1.463** 0.297 
     
Log-likelihood -965.91  -537.90  
AIC 1948.82  1111.79  
BIC 2002.50  1217.14  
No. observations 2572  2572  
No. of respondents 221  221  
*Assumed positive; **P<0.001; AIC = Akaike Information Criterion; BIC = Bayesian 
Information Criterion 
 
Table 4: Willingness to pay and wait for service attributes [mixed logit model] 
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Level 
Willingness to pay (£) Willingness to wait (Days) 
Mean 
Lower 
CI 
Upper 
CI  
Lower 
CI 
Upper 
CI 
Waiting time (Days) £7.72 £4.60 £10.83 N/A 
Specialist pain nurse £20.70 £6.51 £34.89 3.06 1.13 0.18 
GP £23.80 £14.16 £33.44 3.26 1.84 5.00 
Cost N/A 0.13 0.08 0.18 
Poor side-effect control £33.87 £22.17 £45.58 4.53 3.13 5.93 
Poor communication £27.37 £17.67 £37.07 3.57 2.47 4.68 
Poor information £34.42 £22.70 £46.15 4.42 3.17 5.68 
Moderate pain control £19.72 £6.61 £32.83 2.74 0.79 4.68 
Poor pain control £83.30 £57.06 £109.54 11.18 8.34 14.02 
 
 
Figure 1: Preference weights for service attributes [effects coded, conditional logit results] 
 
 
 
 
Supplementary Table A: Long list of potential attributes 
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Category Attribute 
Pain control Level of pain control 
Sleep quality following pain control 
Chance of admission to hospital due to uncontrolled pain 
Pain control during chemotherapy 
Access issues Access to advice on pain 
Length of wait to see your GP/Consultant 
Chance of running out of your pain medication at home 
Pain medication was delivered or needed to be picked up 
Side-effects Control over the pain medication side-effects 
Education and knowledge Confidence in taking the right amount of morphine 
The type of healthcare professional who treats you 
GP knowledge of your treatment options 
Having the same contact person 
Amount of information provided about pain treatments 
Level of communication between you, the pharmacist and your GP 
Costs  Out-of-pocket costs 
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Supplementary Table B: Interactions [conditional logit] 
Interactions of attribute x sub-group variable were tested individually. Only significant interactions (where p<0.05) from these are reported below. 
Sub-group 
Interaction  
(Sub-group#attribute level) 
E SE Z value P value N AIC Interpretation 
Gender 
Male#Side-effects 
-0.387 0.190 -2.03 0.042 2572 1947.7 Males are much more averse to poor side-effect control 
than females 
Pain severity group 
Severe Pain#Wait 
0.113 0.045 2.51 0.012 2554 1929.6 Those who are mild are more averse to waiting for advice 
and treatment 
Pain relief group 
Good relief#Wait 
0.156 0.046 3.41 0.001 2500 1894.1 Those with poor pain relief are less willing to wait for 
treatment 
HRQoL group 
High HRQoL#Side effects 
0.432 0.194 2.23 0.026 2560 1941.4 Those with low HRQoL are much more averse to poor side-
effect control than those with higher HRQoL 
 
High HRQoL#Wait 
0.142 0.046 3.11 0.002 2560 1936.6 Those with low HRQoL are less willing to wait for 
treatment than those with higher HRQoL 
 
High HRQoL#Cost 
-0.018 0.008 -2.31 0.021 2560 1941.0 
Those with low HRQoL are willing to incur higher  out-of-
pocket costs in receiving treatment than those with higher 
HRQoL 
Duration group 
Long duration#Moderate pain 
-0.137 0.235 -0.58 0.56 
 
 
 
 
Long duration#Severe pain 
-0.520 0.248 -2.1 0.036 2528 1931.5 Those who have had cancer for longer are more averse to 
severe pain than those who have had it for less time 
NHS Cost group 
High cost#Wait 
-0.109 0.045 -2.44 0.015 2572 1945.9 Those with higher costs/health care use are much more 
averse to waiting for services than lower cost individuals 
Informal carer group 
Has carer#Specialist Nurse 
0.090 0.237 0.38 0.704 
 
 
 
 
 
Has carer#GP 
0.570 0.238 2.39 0.017 2572 1947.4 Those who have a carer are much more likely to accept 
healthcare provision by a GP than those without a carer 
 
Has carer#Cost 
0.022 0.008 2.71 0.007 2572 1944.4 Those with a carer are willing to incur higher out-of-pocket 
costs in receiving treatment than those without a carer 
AIC = Akaike Information Criterion 
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1. Please consider the two options below. They describe different services that may be available for cancer-
related pain management. We would like you to think about the aspects of each service and to choose 
which one you would prefer to receive.  
 
Please tick one box to indicate which service you would prefer 
  Service 1: Service 2: 
Waiting time for reliable medical advice and pain treatment 1 to 2 days No Wait (Immediate) 
The healthcare professional who is responsible for your pain management Specialist Pain Doctor Specialist Nurse 
Out-of-pocket cost to you per month (e.g. costs such as prescriptions, travel, parking 
& telephone calls that you would have to pay) £30 £0 
Level of control over the side-effects of pain treatments Poor control Good control 
Level of communication between your GP, pharmacist and you Poor Poor 
You are given information which makes you confident about taking the right amount 
of morphine No Yes 
Level of pain control during the day and night Moderate Control Poor Control 
Please tick only one option:   
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IMPACCT Health Economic Patient Preference Focus Groups 
Discussion Guide 
 
 
Welcome and Introductions Time: 3 mins 
x Introduce facilitator and rapporteur 
x Introduce Academic Unit of Health Economics 
x Introduce IMPACCT project - aims 
Aims of session Time: 3 mins 
x To talk to people with experience of cancer-related pain 
x Get an understanding of what is important to them in terms of the care they receive 
x To generate an open discussion (not a question and answer session) 
Ground rules and participant introductions Time: 3 mins 
x Explain the role of the facilitator and rapporteur 
x Cover confidentiality and anonymity 
x Consent forms 
x :HZRXOGOLNHWRDXGLRUHFRUGWKHVHVVLRQMXVWWRPDNHVXUHZHGRQ¶WPLVVDQ\LPSRUWDQW
points ± any names mentioned will be wiped from the audio transcripts 
x Ask participants to introduce themselves and brief details of their illness history 
x Any questions before starting? 
Question 1: Time: 15 mins 
 
What has been your experience of receiving treatment for your cancer pain? What 
were the good and bad points in the care you received? 
Probes 
Location of care 
Access to healthcare staff (e.g. for assessment/advice) 
Access to treatment (ease/convenience and speed) 
24 
 
Efficacy of treatment 
Assessment and management of side effects 
 constipation, 
 mental cloudiness/sleepiness, 
 mood changes/alterations, 
 nausea,  
 respiratory depression,  
 sleep disorders/ hallucinations, 
 sweating 
 vomiting 
Expertise of staff (which types) 
Time spent with healthcare staff 
Level of personal control over treatment and decisions 
Communication with healthcare/voluntary sector staff 
Sufficient follow-up? 
In line with expectations? 
 
Question 2: Time: 15 mins 
 
What are the most important aspects of cancer pain management for you? 
Probes 
Location of care 
Access to healthcare staff (e.g. for assessment) 
Access to treatment (ease/convenience and speed) 
Efficacy of treatment 
Assessment and management of side effects 
Expertise of staff (which types) 
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Time spent with healthcare staff 
Level of personal control over treatment and decisions 
Communication with healthcare/voluntary sector staff 
Sufficient follow-up? 
In line with expectations? 
Question 3: Time: 15 mins 
 
If you were designing a service to provide cancer pain care what would it look like? 
Probes 
Ask why participants choose factors they do 
Is there a consensus in the group about factors? 
If not, why? Subgroup factors? 
  
Question 4: Time: 10 mins 
 
How does management of cancer pain affect your carers/friends and family? 
Probes 
Additional time or travel required? 
Practical implications for care they provide? 
Emotional impact? 
 
Additional questions from discussion Time: 5 mins 
 
26 
 
Summary  Time: 5 mins 
x Run through and check key factors and discussions 
x Anything missed from discussions? 
Session end Time: 2 mins 
x Complete socio-demographic questionnaire 
x Re-iteration of confidentiality and anonymity 
x Thanks for participation 
Total time: 1 hr 16 mins 
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Analysis plan IMPACCT focus groups analysis  
 
The data collected in the focus groups was subjected to a thematic analysis in order to gain a sense 
of the predominant or important themes. The themes identified, categorized, coded and analysed 
therefore serve as a reflection of the entire data set offering a rich overall description.  
 
Thematic analysis was undertaken following the recommendations set by Braun and Clarke (2006) as 
ĂŵĞĂŶƐŽĨ ‘ŝĚĞŶƚŝĨǇŝŶŐ ?ĂŶĂůǇƐŝŶŐĂŶĚƌĞƉŽƌƚŝŶŐƉĂƚƚĞƌŶs (themes) within data. Firstly, the transcripts 
of the audio recording were read to identify meaningful units of text relevant to the research topic. 
Second, units of text dealing with the same issue were grouped together in analytic categories and 
given provisional definitions. The same unit of text could be included in more than one category. The 
interpretation of these themes was conducted by a process of reading and re-reading. Third, the 
data were systematically reviewed to ensure that a name, definition, and exhaustive set of data to 
support each category were identified. Once coding was complete the data was examined for 
differences and commonalities both within and across code categories. Finally themes were grouped 
into a thematic diagram in order to interpret the interrelationships.  
 
 
Themes for discussion and development: 
 
Supply Management 
- Planning/ordering ahead to ensure they have enough pain medication 
- Worry/panic caused from low stock, especially at weekends 
- Pharmacist role; communication with GP helpful 
- Problems with delivery service; orders not always correct.  
- Inflexible delivery times: Tied to home waiting for delivery  W “dŚĞǇĐĂŶ ?ƚŐŝǀĞǇŽƵĂ
ƚŝŵĞ ?zŽƵ ?ǀĞŐŽƚƚŽďĞŝŶĂůůĚĂǇ ? 
- New packaging can cause issues. New types of tablet can lead to problems 
swallowing 
- Day-centre plays an important role in re-assessing medications & solving problems 
- Having organised pill boxes; problems remembering reduced  W “ƚŚĞŶ/ŬŶŽǁ/ ?ǀĞ
ƚĂŬĞŶƚŚĞŵĂŶĚ/ ?ǀĞŶŽƚƚĂŬĞŶƚŽŽŵĂŶǇ ? 
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- GP computer places limitations on prescription renewals 
 
Day-Centre/Hospice 
- Helps to avoid A&E and hospitals 
- Some were not aware of benefits of attending as a day patient. One patient thought 
there would be no exit on entry. 
- Re-assessing pain relief & sorting problems with GP & pharmacy 
- Friendly & empathising 
- Role of nurses at day-centre valued 
 
Sleep 
- Pain meds cause drowsiness 
- Sleeping at day time 
- Disturbed sleep at night due to pain & discomfort 
- Lack of comfort; trouble breathing; joint pain at night 
- Aids (E.g. pillows and grab-rails) for comfortable sleep & getting out of bed 
 
Morphine/Morphine Education 
- Side-effects; constipation, drowsiness, appetite etc.  
- Building up a tolerance over time might make it tough to keep track 
- &ŝŶĚŝŶŐƚŚĞƌŝŐŚƚďĂůĂŶĐĞďĞƚǁĞĞŶƉĂŝŶĐŽŶƚƌŽůĂŶĚďĞŝŶŐ “ŬŶŽĐŬĞĚŽƵƚ ? 
- Some patients avoid taking morphine due to side-effects & fear of overdose; using 
other therapies instead; E.g. hot-water bottle, hot bath (Morphine education) 
 
24hour access/Specialist Access for Cancer 
- Longer appointments would be helpful as ƉĂƚŝĞŶƚƐǁŽƵůĚŶ ?ƚĨĞĞůƌƵƐŚĞĚ 
- GPs should have a good knowledge of pain medication and new pain relief 
treatments 
- GP familiarity with case and patient history; continuity of care 
- Avoiding A&E: emergency out of hours access to pain relief 
- Understanding of patients physical and emotional difficulties 
- Pharmacy links to GP helpful 
- More accessible, both GPs and consultants 
 
Psycho-social side 
- Distress caused by cancer pain -  “A constant reminder that you have cancer ? ? 
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- Impatience and envy of healthy people; Intolerant of their minor health problems 
- Involving family in pain management allows them to feel useful 
- ^ŽĐŝĂůůŝĨĞ ?WĂŝŶƵŶƉƌĞĚŝĐƚĂďůĞƐŽĐĂŶ ?ƚƉůĂŶĂŚĞĂĚ 
- Sexual relations suffer 
- Self-care deteriorates due to pain 
 
Mobility Aids and House-Modifications 
- Sleeping aids to promote restful sleep 
- Grab rails for getting in/out of bed and bath 
 
Chemo & Co-morbities 
- Side-effects & impact on pain management 
 
 
 
 
30 
 
 
Samples completing survey blocks* 
Block No. n Percent Cumulative 
1 38 17.19 17.19 
2 33 14.93 32.13 
3 36 16.29 48.42 
4 34 15.38 63.80 
5 42 19.00 82.81 
6 38 17.19 100.00 
Total 221   
*Pair specific samples not presented as they were unique to each block and missing data were 
minimal 
 
 
 
 
 
